Biotech Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

ArQule, Inc.

Biotech company reports net loss of $0.03 per share

For the quarter, ArQule's revenues were $15,653,000, compared with $13,968,000, for the same period of 2002. The company reported a net loss of $750,000, or $0.03 per share, for the first quarter of 2003, compared with a net loss of $8,375,000, or $0.40 per share, for the first quarter of 2002. Net loss for the first quarter of 2002 included stock-based compensation and amortization of purchased intangibles of $1,767,000 and $844,000, respectively.

ArQule ended the first quarter of 2003 with approximately $83 million in cash and marketable securities.

...

• View Other Issues of Biotech Week
  
• View Other NewsRx Publications